Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Silva

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Respirology (Carlton, Vic.)|February 11, 2025
Early-to-Midlife Body Mass Index Trajectories and Obstructive Sleep Apnoea Risk 10 Years LaterYaoyao Qian, Jennifer L Perret, Garun S Hamilton, et al.
Nature Communications|March 27, 2023
Large haploblocks underlie rapid adaptation in the invasive weed Ambrosia artemisiifoliaPaul Battlay, Jonathan Wilson, Vanessa C Bieker, et al.
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
BMC Gastroenterology|March 23, 2010
Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based surveyMadunil A Niriella, Arjuna P De Silva, Asangi H G K Dayaratne, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 1, 2019
Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort studyMadunil A Niriella, Anuradhani Kasturiratne, Thulani U Beddage, et al.
Hepatology International|December 13, 2018
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri LankaMadunil Anuk Niriella, A Kasturiratne, A Pathmeswaran, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Respirology (Carlton, Vic.)|February 11, 2025
Early-to-Midlife Body Mass Index Trajectories and Obstructive Sleep Apnoea Risk 10 Years LaterYaoyao Qian, Jennifer L Perret, Garun S Hamilton, et al.
Nature Communications|March 27, 2023
Large haploblocks underlie rapid adaptation in the invasive weed Ambrosia artemisiifoliaPaul Battlay, Jonathan Wilson, Vanessa C Bieker, et al.
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
BMC Gastroenterology|March 23, 2010
Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based surveyMadunil A Niriella, Arjuna P De Silva, Asangi H G K Dayaratne, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 1, 2019
Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort studyMadunil A Niriella, Anuradhani Kasturiratne, Thulani U Beddage, et al.
Hepatology International|December 13, 2018
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri LankaMadunil Anuk Niriella, A Kasturiratne, A Pathmeswaran, et al.
JAMA|August 19, 2018
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical TrialRuth Webster, Abdul Salam, H Asita de Silva, et al.
Global Heart|November 3, 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of HypertensionAbdul Salam, H Asita de Silva, Dike Ojji, et al.
Journal of Gastroenterology and Hepatology|February 18, 2022
Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' ConsortiumRupa Banerjee, Partha Pal, Ida Hilmi, et al.
Pageof 16